scholarly journals Intracardiac thrombosis in Behçet's Disease successfully treated with immunosuppressive agents: A case of vascular pathergy phenomenon

2018 ◽  
Vol 7 (1) ◽  
pp. 54-57 ◽  
Author(s):  
Francisco Galeano-Valle ◽  
Pablo Demelo-Rodriguez ◽  
Luís Álvarez-Sala-Walther ◽  
Blanca Pinilla-Llorente ◽  
Miguel Jesús Echenagusia-Boyra ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Immunosuppressive Agents ◽  
Behcet's Disease ◽  
Pathergy Phenomenon ◽  
Intracardiac Thrombosis

scholarly journals A case of intestinal Behcet’s disease under Adalimumab

2017 ◽  
Vol 4 (3) ◽  
pp. 62
Author(s):  
David T. Dulaney ◽  
Wassem Juakiem ◽  
Katherine Cebe ◽  
Angelo H. Paredes
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Immunosuppressive Agents ◽  
African American Female ◽  
Behcet's Disease ◽  
Oral Ulcers ◽  
Adalimumab Therapy ◽  
Tnfα Inhibitors ◽  
Tnfα Inhibitor

Behcet’s disease (BD) is a multisystem mucocutaneous inflammatory condition characterized by recurrent genital and oral ulcers, ocular inflammation, and can involve the gastrointestinal tract. Treatment involves the usage of immunosuppressive agents to control the disease with glucocorticoids utilized for treatment of flares. Tumor necrosis factor inhibitors are frequently used to control the disease as well. We present the case of a 40 years old African American female presenting with intestinal BD that was refractory to adalimumab therapy. In conjunction with glucocorticoids, the patient’s intestinal disease was controlled with infliximab therapy. Currently, there have been no studies comparing the efficacy of TNFα inhibitors on the treatment of BD. Future studies are needed to compare the efficacy of TNFα inhibitor agents in the treatment of intestinal manifestations of BD.

P 084 Relationship of pathergy phenomenon and Behçet's disease (BD) manifestations

1993 ◽  
Vol 14 ◽  
pp. 96s ◽  
Author(s):  
P. Mansoori ◽  
C. Chams ◽  
F. Davatchi ◽  
F. Shahram ◽  
M. Akbarian ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Behcet's Disease ◽  
Pathergy Phenomenon ◽  
Relationship Of

scholarly journals Intracardiac thrombosis in Behçet's disease: a life threatening event

2017 ◽  
Vol 57 (1) ◽  
pp. 85-87
Author(s):  
Pedro Madureira ◽  
Mariana Rodrigues ◽  
Edite Serrano ◽  
Artur Bonito Vítor ◽  
Iva Brito
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Behcet's Disease ◽  
Life Threatening ◽  
Life Threatening Event ◽  
Intracardiac Thrombosis

scholarly journals Behçet's disease and intracardiac thrombosis

2022 ◽  
Vol 14 (1) ◽  
pp. 134
Author(s):  
M. Ben Brahim ◽  
S. Daada ◽  
A. Achour ◽  
I. Chaaben ◽  
R.I.M. Klii ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Behcet's Disease ◽  
Intracardiac Thrombosis

scholarly journals New Evidence-Based Treatment Approach in Behçet's Disease

2012 ◽  
Vol 2012 ◽  
pp. 1-11 ◽  
Author(s):  
Erkan Alpsoy
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Age Of Onset ◽  
Behçet's Disease ◽  
Systemic Vasculitis ◽  
Severe Disease ◽  
Immunosuppressive Agents ◽  
Evidence Based ◽  
Close Monitoring ◽  
Behcet's Disease

Behçet's disease (BD) is a chronic, relapsing, and debilitating systemic vasculitis of unknown aetiology with the clinical features of mucocutaneous lesions, ocular, vascular, articular, neurologic, gastrointestinal, urogenital, and pulmonary involvement. The disease is much more frequent along the ancient “Silk Route” extending from Eastern Asia to the Mediterranean basin, compared with Western countries. The disease usually starts around the third or fourth decade of life. Male sex and a younger age of onset are associated with more severe disease. Although the treatment has become much more effective in recent years, BD is still associated with severe morbidity and considerable mortality. The main aim of the treatment should be the prevention of irreversible organ damage. Therefore, close monitoring, early, and appropriate treatment is mandatory to reduce morbidity and mortality. The treatment is mainly based on the suppression of inflammatory attacks of the disease using immunomodulatory and immunosuppressive agents. In this paper, current state of knowledge regarding the therapeutic approaches is outlined. To provide a rational framework for selecting the appropriate therapy along the various treatment choices, a stepwise, symptom-based, evidence-based algorithmic approach was developed.

scholarly journals A rarely seen manifestation in Behcet’s disease: intracardiac thrombosis

2021 ◽  
Author(s):  
Reşit Yıldırım ◽  
Mustafa Dinler ◽  
Nazife Şule Yaşar Bilge ◽  
Timuçin Kaşifoğlu
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Behcet's Disease ◽  
Intracardiac Thrombosis

Intracardiac Thrombosis Associated With Behçet’s Disease

2010 ◽  
Vol 63 (12) ◽  
pp. 1513-1515 ◽  
Author(s):  
Ana Moreno-Rodrigo ◽  
Josefa Muñoz-Sánchez ◽  
Francisco Javier Bóveda-Romeo ◽  
Juan Miguel Santamaría-Jáuregui
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Behcet's Disease ◽  
Intracardiac Thrombosis
Sign in / Sign up

Export Citation Format

Share Document